Skip to content

Clinical trials

Completed Metabolic Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Status: Completed Country / region: France Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20092
20104
20114
20122
20131
20142
20182
20191
20202
20211
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Assistance Publique - Hôpitaux de Paris2
Eli Lilly and Company2
Institut National de la Santé Et de la Recherche Médicale, France2
LYSOGENE2
Nantes University Hospital2
89bio, Inc.1
Alnylam Pharmaceuticals1
Centre Hospitalier Universitaire de Nice1
Centre Hospitalier Universitaire de la Réunion1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases26
Diabetes Mellitus6
Diabetes Mellitus, Type 26
Endocrine System Diseases5
Glucose Metabolism Disorders5
Obesity5
Dyslipidemias3
Genetic Diseases, Inborn3
Body Weight2
Cystinosis2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.